UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 221.

A

Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; ... Machin, SJ; + view all (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Aligianis, IA; Forshew, T; Johnson, S; Michaelides, M; Johnson, CA; Trembath, RC; ... Maher, ER; + view all (2002) Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J MED GENET , 39 (9) 656 - 660.

Allcock, RJN; Atrazhev, AM; Beck, S; de Jong, PJ; Elliott, JF; Forbes, S; ... Williams, S; + view all (2002) The MHC haplotype project: A resource for HLA-linked association studies. TISSUE ANTIGENS , 59 (6) 520 - 521.

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Arcaro, A; Khanzada, UK; Vanhaesebroeck, B; Tetley, TD; Waterfield, MD; Seckl, MJ; (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO J , 21 (19) 5097 - 5108.

Ardeshna, KM; Pizzey, AR; Walker, SJ; Devereux, S; Khwaja, A; (2002) The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3 beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. BRIT J HAEMATOL , 119 (3) 826 - 829.

Attygalle, A; Al-Jehani, R; Diss, TC; Munson, P; Liu, HX; Du, MQ; ... Dogan, A; + view all (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. BLOOD , 99 (2) 627 - 633. 10.1182/blood.V99.2.627.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; ... Dogan, A; + view all (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. MODERN PATHOL , 15 (1) 229A - 230A.

Attygalle, AD; Al-Jehani, R; Diss, TC; Munson, P; Liu, H; Du, MQ; ... Dogan, A; + view all (2002) Characterisation of T-cells expressing CD10 in angioimmunoblastic T-cell lymphoma. LAB INVEST , 82 (1) 229A - 230A.

B

Baraldi, PG; Romagnoli, R; Guadix, AE; de las Infantas, MJP; Gallo, MA; Espinosa, A; ... Hartley, JA; + view all (2002) Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. J MED CHEM , 45 (17) 3630 - 3638. 10.1021/jm011113b.

Baraldi, PG; Romagnoli, R; Pavani, MG; Nunez, MD; Bingham, JP; Hartley, JA; (2002) Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity. BIOORGAN MED CHEM , 10 (5) 1611 - 1618.

Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; ... Albanell, J; + view all (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Bates, AW; (2002) Conjoined twins in the 16th century. TWIN RES , 5 (6) 521 - 528.

Bates, AW; (2002) Documentary evidence for conjoined twins in the sixteenth century. AM J MED GENET , 112 (4) 430 - 431. 10.1002/ajmg.10749.

Bates, AW; Baithun, SI; (2002) Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases. VIRCHOWS ARCH , 440 (4) 392 - 396. 10.1007/s004280100505.

Bates, AW; Baithun, SI; (2002) The significance of secondary neoplasms of the urinary and male genital tract. VIRCHOWS ARCH , 440 (6) 640 - 647. 10.1007/s00428-001-0549-x.

Bates, AW; Hall, CM; Morgan, H; Rosser, EM; Scheimberg, I; (2002) Lethal acrofacial dysostosis, pre- and post-axial defects of the hands, and bilateral renal agenesis. CLIN DYSMORPHOL , 11 (1) 63 - 66.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Beauregard, DA; Pedley, RB; Hill, SA; Brindle, KM; (2002) Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS. NMR BIOMED , 15 (2) 99 - 105. 10.1002/nbm.723.

Belorgey, D; Crowther, DC; Mahadeva, R; Lomas, DA; (2002) Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. J Biol Chem , 277 (19) 17367 - 17373. 10.1074/jbc.M200680200. Gold open access

Bernstein, HG; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; ... Baumann, B; + view all (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 91 - 93.

Best, JL; Ganiatsas, S; Agarwal, S; Changou, A; Salomoni, P; Shirihai, O; ... Zon, LI; + view all (2002) SUMO-1 protease-1 regulates gene transcription through PML. MOL CELL , 10 (4) 843 - 855.

Biganzoli, L; Cufer, T; Bruning, P; Coleman, R; Duchateau, L; Calvert, AH; ... Piccart, MJ; + view all (2002) Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. J CLIN ONCOL , 20 (14) 3114 - 3121. 10.1200/JCO.2002.11.005.

Boshoff, C; Weiss, R; (2002) Aids-related malignancies. NAT REV CANCER , 2 (5) 373 - 382. 10.1038/nrc797.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; ... Mackinnon, S; + view all (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J CLIN ONCOL , 20 (19) 4022 - 4031. 10.1200/JCO.2002.11.088.

Broceño, C; Wilkie, S; Mittnacht, S; (2002) RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A , 99 (22) 14200 - 14205. 10.1073/pnas.212519499.

Brock, CS; Lee, SM; (2002) Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. Eur Respir J , 19 (3) 557 - 570.

Budhram-Mahadeo, V; Morris, P; Ndisang, D; Irshad, S; Lozano, G; Pedley, B; Latchman, DS; (2002) The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. NEUROSCI LETT , 334 (1) 1 - 4.

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emmott, J; Wong, WL; (2002) Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [F-18]- fluorodeoxyglucose positron emission tomography. European Journal of Cancer , 38 (3) 375 - 379.

Byrne, E; (2002) Autoimmune myasthenia gravis: place of thymectomy and preferredtechnique. Internal Medicine Journal , 32 (8) 365 - 366.

Byrne, E; (2002) Does mitochondrial respiratory chain dysfunction have a role in common neurodegenerative disorders? Journal of Clinical Neuroscience , 9 (5) 497 - 501.

C

Calvert, H; Bunn, PA; (2002) Future directions in the development of pemetrexed. SEMINARS IN ONCOLOGY , 29 (2) 54 - 61. 10.1053/sonc.2002.30761.

Carrell, RW; Lomas, DA; (2002) Alpha1-antitrypsin deficiency--a model for conformational diseases. N Engl J Med , 346 (1) 45 - 53. 10.1056/NEJMra010772.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; ... Milligan, DW; + view all (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; ... Milligan, DW; + view all (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Chakraverty, R; Peggs, K; Chopra, R; Milligan, DW; Kottaridis, PD; Verfuerth, S; ... Mackinnon, S; + view all (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. BLOOD , 99 (3) 1071 - 1078.

Chantret, I; Dupré, T; Delenda, C; Bucher, S; Dancourt, J; Barnier, A; ... Moore, SE; + view all (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem , 277 (28) 25815 - 25822. 10.1074/jbc.M203285200. Gold open access

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) 607 - 610. 10.1038/sj.bmt.1703421.

Chow, E; Wu, JSY; Hoskin, P; Coia, LR; Bentzen, SM; Blitzer, PH; (2002) International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiotherapy And Oncology , 64 (3) 275 - 280.

Clark, FJ; Chakraverty, R; (2002) Role of dendritic cells in graft-versus-host disease. J HEMATOTH STEM CELL , 11 (4) 601 - 616.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 32 (11) 3246 - 3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Colombari, R; Togni, R; Furlanetto, A; Quaglia, A; Dhillon, A; Demichelis, F; ... Dhillon, AP; + view all (2002) Royal free (RFH) scoring system for unifocal hepatocellular carcinoma (HCC) < 5 cm diameter: A valuable prognostic tool. J HEPATOL , 36 78 - 78.

Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG; (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. NAT CELL BIOL , 4 (7) 529 - 533. 10.1038/ncb814.

Cooke, SP; Pedley, RB; Boden, R; Begent, RHJ; Chester, KA; (2002) In vivo tumor delivery of a recombinant single-chain Fv::Tumor necrosis factor: A fusion protein. BIOCONJUGATE CHEM , 13 (1) 7 - 15. 10.1021/bc000178a.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; ... Little, AM; + view all (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) 49 - 51.

Craddock, C; Hochhauser, D; (2002) Realising the potential of targeted therapies in oncology. LANCET , 360 (9331) 424 - 425.

Crotaz, GR; Solanki, C; Ballinger, JR; Parmar, JS; Lomas, DA; Chilvers, ER; (2002) A novel method of radiolabelling alpha(1)-antitrypsin monomer and polymers. JOURNAL OF NUCLEAR MEDICINE , 43 (5) , Article UNSP 200192.

D

Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; ... Futreal, PA; + view all (2002) Mutations of the BRAF gene in human cancer. Nature , 417 (6892) 949 - 954. 10.1038/nature00766.

Davies, JK; Koh, MB; Prentice, HG; Lowdell, MW; (2002) Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. BONE MARROW TRANSPL , 29 S45 - S46.

Davis, RL; Shrimpton, AE; Carrell, RW; Lomas, DA; Gerhard, L; Baumann, B; ... Holohan, PD; + view all (2002) Association between conformational mutations in neuroserpin and onset and severity of dementia. Lancet , 359 (9325) 2242 - 2247. 10.1016/S0140-6736(02)09293-0.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2002) Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. NUCLEIC ACIDS RES , 30 (17) 3848 - 3856. Gold open access

Diss, TC; Liu, HX; Du, MQ; Isaacson, PG; (2002) Improvements to B-cell clonality analysis using PCR amplification of immunoglobin light chain genes. Molecular Pathology , 55 (2) 98 - 101.

Donohoe, S; Quenby, S; Mackie, I; Panal, G; Farquharson, R; Malia, R; ... Machin, S; + view all (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. LUPUS , 11 (1) 11 - 20. 10.1191/0961203302lu132oa.

Du, MQ; Isaacson, PG; (2002) Gastric MALT lymphoma: from aetiology to treatment. The Lancet Oncology , 3 97 - 104.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; ... Madrigal, JA; + view all (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 66 - 66.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; ... Madrigal, JA; + view all (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens , 59 (6) 522 - 524.

E

Ezoe, S; Matsumura, I; Nakata, S; Gale, K; Ishihara, K; Minegishi, N; ... Kanakura, Y; + view all (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. BLOOD , 100 (10) 3512 - 3520.

F

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; ... Begent, RHJ; + view all (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. In: CANCER. (pp. 1249 - 1257). JOHN WILEY & SONS INC

Forbes, LV; Gale, RE; Pizzey, A; Pouwels, K; Nathwani, A; Linch, DC; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. ONCOGENE , 21 (39) 5981 - 5989. 10.1038/sj.onc.1205767.

Freeman, A; Treurnicht, K; Munson, P; Miller, K; Parkinson, MC; (2002) A comparison of basal cell markers used in the prostate. HISTOPATHOLOGY , 40 (5) 492 - 494.

G

Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, AG; ... Gazzard, B; + view all (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. JAIDS-J ACQ IMM DEF , 31 (4) 384 - 390.

Going, JJ; Keith, WN; Neilson, L; Stoeber, K; Stuart, RC; Williams, GH; (2002) Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. GUT , 50 (3) 373 - 377. Green open access
file

Goldring, K; Jones, GE; Poirier, F; Prasad, R; Tavsanoglu, Y; Watt, DJ; (2002) The galectin-1 null mouse furthers the understanding of the role of galectin-1 in muscle formation, differentiation and regeneration. In: NEUROMUSCULAR DISORDERS. (pp. 719 - 720). PERGAMON-ELSEVIER SCIENCE LTD

Goldring, K; Jones, GE; Sewry, CA; Watt, DJ; (2002) The muscle-specific marker desmin is expressed in a proportion of human dermal fibroblasts after their exposure to galectin-1. NEUROMUSCULAR DISORD , 12 (2) 183 - 186.

Goldring, K; Jones, GE; Thiagarajah, R; Watt, DJ; (2002) The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J CELL SCI , 115 (2) 355 - 366.

Goldring, K; Partridge, T; Watt, D; (2002) Muscle stem cells. J PATHOL , 197 (4) 457 - 467. 10.1002/path.1157.

Gordon, FH; Hamilton, MI; Donoghue, S; Greenlees, C; Palmer, T; Rowley-Jones, D; ... Pounder, RE; + view all (2002) A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. ALIMENT PHARM THER , 16 (4) 699 - 705.

Gore, M; Oza, A; Rustin, G; Malfetano, J; Calvert, H; Clarke-Pearson, D; ... Fields, SZ; + view all (2002) A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. EUR J CANCER , 38 (1) 57 - 63.

Grimaldi, KA; McGurk, CJ; McHugh, PJ; Hartley, JA; (2002) PCR-based methods for detecting DNA damage and its repair at the sub-gene and single nucleotide levels in cells. MOL BIOTECHNOL , 20 (2) 181 - 196.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; ... Solomon, E; + view all (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

GUPTA, R; Bain, BJ; (2002) Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol , 107 (2) 123 - 128. 10.1159/000046642.

H

Hale, G; Slavin, S; Goldman, JM; Mackinnon, S; Giralt, S; Waldmann, H; (2002) Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nomnyeloablative conditioning? BONE MARROW TRANSPL , 30 (12) 797 - 804. 10.1038/sj.bmt.1703733.

Hanawa, H; Kelly, PF; Nathwani, AC; Persons, DA; Vandergriff, JA; Hargrove, P; ... Nienhuis, AW; + view all (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Molecular Therapy , 5 (3) 242 - 251.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100((R)): a potential rapid screening tool for the assessment of platelet dysfunction. CLIN LAB HAEMATOL , 24 (4) 225 - 232.

Heelan, BT; Tormey, V; Amlot, PL; Payne, E; Mehta, A; Webster, AD; (2002) Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology , 118 (4) 1078 - 1081.

Heyworth, C; Pearson, S; May, G; Enver, T; (2002) Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J , 21 (14) 3770 - 3781.

Hoskin, PJ; (2002) FDG PET in the management of lymphoma: a clinical perspective. European Journal of Nuclear Medicine and Molecular Imaging , 29 (4) 449 - 451.

Howard, J; Hoffbrand, AV; Prentice, HG; Mehta, A; (2002) Mycophenolate mofetil for the treatment of refractory auto- immune haemolytic anaemia and auto-immune thrombocytopenia purpura. British Journal of Haematology , 117 (3) 712 - 715.

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; ... Lee, M; + view all (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. BIOORGAN MED CHEM , 10 (9) 2941 - 2952.

Hughes, A; Calvert, P; Azzabi, A; Plummer, R; Johnson, R; Rusthoven, J; ... Calvert, H; + view all (2002) Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J CLIN ONCOL , 20 (16) 3533 - 3544. 10.1200/JCO.2002.10.073.

Hughes, SE; (2002) Cardiac stem cells. The Journal of Pathology (197) 468 - 478.

Huntly, BJP; Bench, AJ; Delabesse, E; Reid, AG; Li, J; Scott, MA; ... Green, AR; + view all (2002) Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability. In: BLOOD. (pp. 4547 - 4553). AMER SOC HEMATOLOGY

J

Janinis, J; McTiernan, A; Driver, D; Mitchell, C; Cassoni, AM; Pringle, J; ... London Bone and Soft Tissue Tumour,; + view all (2002) A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. ANN ONCOL , 13 (12) 1935 - 1944. 10.1093/annonc/mdf338.

Jenner, RG; Boshoff, C; (2002) The molecular pathology of Kaposi's sarcoma-associated herpesvirus. BBA-REV CANCER , 1602 (1) 1 - 22.

Jennings, BH; (2002) Stopping Transcription in its Tracks. Nature Genetics , 32 87 - 88.

Jennings, I; Greaves, M; Mackie, IJ; Kitchen, S; Woods, TAL; Preston, FE; UK Natl External Quality Assessmen,; (2002) Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. BRIT J HAEMATOL , 119 (2) 364 - 369.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; ... Wickremasinghe, RG; + view all (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access
file

Joshi, CV; Enver, T; (2002) Plasticity revisited. CURR OPIN CELL BIOL , 14 (6) 749 - 755. 10.1016/A0955-0674(02)00392-7.

K

Kapsa, RM; Quigley, AF; Vadolas, J; Steeper, K; Ioannou, PA; Byrne, E; Kornberg, AJ; (2002) Targeted gene correction in the mdX mouse using short DNA fragments: towards application with bone marrow-derived cells for autologous remodeling of dystrophic muscle. Gene Therapy , 9 (11) 695 - 699.

Kapsa, RMI; Wong, SHA; Bertoncello, I; Quigley, AF; Williams, B; Sells, K; ... Kornberg, AJ; + view all (2002) CD45 fraction bone marrow cells as potential delivery vehicles for genetically corrected dystrophin loci. Neuromuscular Disorders , 12 S61 - S66.

Kiakos, K; Howard, TT; Lee, M; Hartley, JA; McHugh, PJ; (2002) Saccharomyces cerevisiae RAD5 influences the excision repair of DNA minor groove adducts. J BIOL CHEM , 277 (46) 44576 - 44581. 10.1074/jbc.M208169200. Gold open access

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) 379 - 388.

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. J Gene Med , 4 (6) 592 - 600. 10.1002/jgm.306.

Kitajima, K; Masuhara, M; Era, T; Enver, T; Nakano, T; (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO J , 21 (12) 3060 - 3069.

Koch, SSC; Thoresen, LH; Tikhe, JG; Maegley, KA; Almassy, RJ; Li, JK; ... Hostomsky, Z; + view all (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J MED CHEM , 45 (23) 4961 - 4974. 10.1021/jm02059n.

Kocjan, G; (2002) Cytopathology of the thyroid. Current Diagnostic Pathology , 8 201 - 205.

Kocjan, G; (2002) Pitfalls in cytology of endocrine organs. CPD Bulletin Cellular Pathology , 4 21 - 29.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; ... Goldstone, AH; + view all (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kottke, TJ; Blajeski, AL; Meng, XW; Svingen, PA; Ruchaud, S; Mesner, PW; ... Kaufmann, SH; + view all (2002) Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. 804 - 815. Gold open access

Kralovicova, J; Marsh, SGE; Waller, MJ; Hammarstrom, L; Vorechovsky, I; (2002) The HLA-DRA*0102 allele: Correct nucleotide sequence and associated HLA haplotypes. Tissue Antigens , 60 (3) 266 - 267.

Kularatne, BY; Lorigan, P; Browne, S; Suvarna, SK; Smith, NO; Lawry, J; (2002) Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. CYTOMETRY , 50 (3) 160 - 167. 10.1002/cyto.10071.

L

Lagging, LM; Garcia, CE; Westin, J; Wejstal, R; Norkrans, G; Dhillon, AP; Lindh, M; (2002) Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J CLIN MICROBIOL , 40 (11) 4224 - 4229. 10.1128/JCM.40.11.4224-4229.2002.

Lagging, LM; Westin, J; Svensson, E; Aires, N; Dhillon, AP; Lindh, M; ... Norkrans, G; + view all (2002) Progression of fibrosis in untreated patients with hepatitis C virus infection. LIVER , 22 (2) 136 - 144.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) 393 - 399. 10.1038/sj.leu.2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Lee, YC; Boehm, MK; Chester, KA; Begent, RHJ; Perkins, SJ; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J MOL BIOL , 320 (1) 107 - 127. 10.1016/S0022-2836(02)00403-5.

Liu, HX; Huang, XB; Zhang, Y; Ye, HT; El Hamidi, A; Kocjan, G; ... Du, MQ; + view all (2002) Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. DIAGN MOL PATHOL , 11 (4) 222 - 227.

Liu, Y; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Le Meuth-Metzinger, VG; ... Ganesan, TS; + view all (2002) Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. ONCOGENE , 21 (3) 387 - 399.

Liu, ZD; Kayyali, R; Hider, RC; Porter, JB; Theobald, AE; (2002) Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators. J MED CHEM , 45 (3) 631 - 639. 10.1021/jm010817i.

Lomas, DA; (2002) Chronic obstructive pulmonary disease. Introduction. Thorax , 57 (8) 735 - ?.

Lomas, DA; Carrell, RW; (2002) Serpinopathies and the conformational dementias. Nat Rev Genet , 3 (10) 759 - 768. 10.1038/nrg907.

Lomas, DA; Lourbakos, A; Cumming, SA; Belorgey, D; (2002) Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia. Biochem Soc Trans , 30 (2) 89 - 92.

Lomas, DA; Mahadeva, R; (2002) alpha(1)-Antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. JOURNAL OF CLINICAL INVESTIGATION , 110 (11) 1585 - 1590. 10.1172/JCI200216782.

Lomas, DA; Mahadeva, R; (2002) Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest , 110 (11) 1585 - 1590. 10.1172/JCI16782.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.

M

Mackie, IJ; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; ... Rumley, A; + view all (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. THROMB HAEMOSTASIS , 87 (6) 997 - 1005.

Mackie, IJ; Lawrie, AS; Purdy, G; Williams, T; Machin, SJ; (2002) DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use. In: BLOOD. (pp. 88B - 89B). AMER SOC HEMATOLOGY

Mackie, J; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GD; ... Rumley, A; + view all (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost , 87 (6) 997 - 1005.

Mackinnon, S; Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; (2002) Characterization of human cytomegalovirus peptide-specific CD8 T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood , 99 (1) 213 - 223. 10.1182/blood.V99.1.213. Green open access
file

Mahadeva, R; Dafforn, TR; Carrell, RW; Lomas, DA; (2002) 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin-related cirrhosis. J Biol Chem , 277 (9) 6771 - 6774. 10.1074/jbc.C100722200. Gold open access

Manderson, EN; Presneau, N; Provencher, D; Mes-Masson, AM; Tonin, PN; (2002) Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. MOL CARCINOGEN , 34 (2) 78 - 90. 10.1002/mc.10051.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. Human Immunology , 63 (12) 1213 - 1268.

Marsh, SGE; Albert E D, B; W F, B; R E, D; B, E; H A, G; ... P, I; + view all (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 407 - 464.

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; McArdle, C; Seymour, MT; ... British MRC Colorectal Canc Work,; + view all (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. LANCET , 359 (9317) 1555 - 1563.

McKelvie, PA; Collins, S; Thyagarajan, D; Trost, N; Sheorey, H; Byrne, E; (2002) Meningoencephalomyelitis with vasculitis due to varicella zoster virus : a case report and review of the literature. Pathology , 34 (1) 88 - 93.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) 118 - 119.

Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC; (2002) Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J BIOL CHEM , 277 (9) 7318 - 7323. 10.1074/jbc.M108795200. Gold open access

Migliorini, D; Denchi, EL; Danovi, D; Jochemsen, A; Capillo, M; Gobbi, A; ... Marine, JC; + view all (2002) Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. MOL CELL BIOL , 22 (15) 5527 - 5538. 10.1128/MCB.22.15.5527-5538.2002.

Mushipe, MT; Revell, PA; Shelton, JC; (2002) Cancellous bone repair using bovine trabecular bone matrix particulates. Biomaterials , 23 (2) 365 - 370. 10.1016/S0142-9612(01)00114-4.

N

Nathwani, A; Davidoff, AM; Hanawa, H; Hu, Y; Hoffer, FA; Nikanorov, A; ... Nienhuis, AW; + view all (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood , 100 (5) 1662 - 1669. 10.1182/blood-2002-02-0589. Green open access
file

Newton, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; ... Uganda Kaposis Sarcoma Study Grp,; + view all (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. BRIT J CANCER , 87 (3) 301 - 308. 10.1038/sj.bjc.6600451.

Nicholson, PW; Harland, SJ; (2002) Survival prospects after screen-detection of prostate cancer. BJU INT , 90 (7) 686 - 693. 10.1046/j.1464-4096.2002.03005.x.

Nikitenko, LL; Smith, DM; Hague, S; Wilson, CR; Bicknell, R; Rees, MCP; (2002) Adrenomedullin and the microvasculature. TRENDS PHARMACOL SCI , 23 (3) 101 - 103.

Niyikiza, C; Baker, SD; Seitz, DE; Walling, JM; Nelson, K; Rusthoven, JJ; ... Allen, RH; + view all (2002) Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy. MOL CANCER THER , 1 (7) 545 - 552.

Niyikiza, C; Hanauske, AR; Rusthoven, JJ; Calvert, AH; Allen, R; Paoletti, P; Bunn, PA; (2002) Pemetrexed safety and dosing strategy. SEMIN ONCOL , 29 (6) 24 - 29. 10.1053/sonc.2002.37465.

O

O'Hare, CC; Mack, D; Tandon, M; Sharma, SK; Lown, JW; Kopka, ML; ... Hartley, JA; + view all (2002) DNA sequence recognition in the minor groove by crosslinked polyamides: The effect of N-terminal head group and linker length on binding affinity and specificity. P NATL ACAD SCI USA , 99 (1) 72 - 77.

Oakley, TJ; Goodwin, A; Chakraverty, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA Repair (Amst) , 1 (6) 463 - 482.

Ohkura, N; Yaguchi, H; Tsukada, T; Yamaguchi, K; (2002) The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J Biol Chem , 277 (1) 535 - 543. 10.1074/jbc.M109018200. Gold open access

Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; ... Vanhaesebroeck, B; + view all (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science , 297 (5583) 1031 - 1034. 10.1126/science.1073560.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; ... Meignin, V; + view all (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) 2331 - 2336.

P

Parmar, JS; Mahadeva, R; Reed, BJ; Farahi, N; Cadwallader, KA; Keogan, MT; ... Lomas, DA; + view all (2002) Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol , 26 (6) 723 - 730. 10.1165/ajrcmb.26.6.4739.

Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; ... ICON Grp,; + view all (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. LANCET , 360 (9332) 505 - 515.

Patel, BD; Tasker, A; Screaton, N; Anderson, W; Sharma, S; Silverman, EK; Lomas, DA; (2002) Smoking related emphysema and small airways disease have independent genetic risk factors in COPD. In: THORAX.

Patel, Y; Moraes, YC; Latchman, D; Coffin, R; de Belleroche, J; (2002) Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. MOL BRAIN RES , 109 (1-2) 189 - 197.

Paul, MJ; Summers, Y; Calvert, AH; Rustin, G; Brampton, MH; Thatcher, N; Middleton, MR; (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. MELANOMA RES , 12 (2) 175 - 178.

Pedley, RB; El-Emir, E; Flynn, AA; Boxer, GM; Dearling, J; Raleigh, JA; ... Begent, RHJ; + view all (2002) Synergy between vascular targeting agents and antibody-directed therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 54 (5) 1524 - 1531.

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Peggs, KS; Mackinnon, S; (2002) Clinical trials with CMV-specific T cells. CYTOTHERAPY , 4 (1) 21 - 28.

Peggs, KS; Mackinnon, S; Yong, K; (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: Determining its role in multiple myeloma. J CLIN ONCOL , 20 (20) 4268 - 4268.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. BLOOD , 99 (12) 4642 - 4643.

Peggs, KS; Paneesha, S; Kottaridis, PD; Chakraverty, RK; Tobias, G; Reilly, M; ... Yong, K; + view all (2002) Peripheral blood stem cell transplantation for POEMS syndrome. BONE MARROW TRANSPL , 30 (6) 401 - 404. 10.1038/sj.bmt.1703670.

Peltékian, E; Garcia, L; Danos, O; (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther , 5 (1) 25 - 32. 10.1006/mthe.2001.0517.

Perera, D; Pizzey, A; Campbell, A; Katz, M; Porter, J; Petrou, M; ... Chatterjee, R; + view all (2002) Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. HUM REPROD , 17 (7) 1820 - 1825.

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; ... Apparailly, F; + view all (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) 2161 - 2172. 10.1089/104303402320987851.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; ... Spanish United Kingdom Collaborat,; + view all (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Peters, GJ; Backus, HHJ; Freemantle, S; van Triest, B; Codacci-Pisanelli, G; van der Wilt, CL; ... Pinedo, HM; + view all (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1587 (2-3) 194 - 205.

Pileri, SA; Grogan, TM; Harris, NL; Banks, P; Campo, E; Chan, JKC; ... Weiss, LM; + view all (2002) Tumours of histiocytes and accessory dendritic cells: An immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology , 41 (1) 1 - 29. 10.1046/j.1365-2559.2002.01418.x.

Platt, G; Carbone, A; Mittnacht, S; (2002) p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene , 21 (12) 1823 - 1831. 10.1038/sj.onc.1205360.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol , 76 (10) 5051 - 5061.

Porter, JB; Davis, BA; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. BEST PRACT RES CL HA , 15 (2) 329 - 368. 10.1053/beha.2002.0214.

Pule, M; Gullmann, C; Dennis, D; McMahon, C; Jeffers, M; Smith, OP; (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. British Journal of Haematology , 118 (4) 991 - 998.

Q

Quaglia, A; Laurent, C; Girlando, S; Saini, J; Dalla Palma, P; Colombari, R; ... Dhillon, AP; + view all (2002) Clonality and genomic heterogeneity in HCC and putative precursor nodular lesions. J HEPATOL , 36 83 - 83.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2002) Autologous thrombin for treatment of pseudoaneurysms. LANCET , 359 (9310) 946 - 947.

R

Radosavljevic, M; Cuillerier, B; Wilson, MJ; Clement, O; Wicker, S; Gilfillan, S; ... Bahram, S; + view all (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. GENOMICS , 79 (1) 114 - 123. 10.1006/geno.2001.6673.

Ravichandran, D; Shenoy, V; Kocjan, G; Ball, RY; Ralphs, DNL; (2002) Touch imprint cytology in the assessment of sentinel lymph node status. EUR J CANCER , 38 S61 - S61.

Reid, AG; Huntly, BJP; Hennig, E; Niederwieser, D; Campbell, LJ; Bown, N; ... Nacheva, EP; + view all (2002) Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. In: BLOOD. (pp. 2274 - 2275). AMER SOC HEMATOLOGY

Robinson, SP; Sureda, A; Mackinnon, S; Carella, A; Taghipour, G; Goldstone, AH; ... Lymphoma Working Party EBMT,; + view all (2002) Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease: An analysis from the European group for Blood and Marrow Transplantation. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

Rosti, G; Ferrante, P; Ledermann, J; Leyvraz, S; Ladenstein, R; Koscileniak, E; ... Marangolo, M; + view all (2002) High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol , 41 (2) 129 - 140.

Rudnicka, AR; Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. PRENATAL DIAG , 22 (10) 893 - 897. 10.1002/pd.440.

S

Salomoni, P; Pandolfi, PP; (2002) p53 de-ubiquitination: at the edge between life and death. NAT CELL BIOL , 4 (6) E152 - E153. 10.1038/ncb0602-e152.

Salomoni, P; Pandolfi, PP; (2002) The role of PML in tumor suppression. CELL , 108 (2) 165 - 170.

Scheuer, PJ; Standish, RA; Dhillon, AP; (2002) Scoring of chronic hepatitis. Clin Liver Dis , 6 (2) 335 - vi.

Sharp, TV; Wang, HW; Koumi, A; Hollyman, D; Endo, Y; Ye, HT; ... Boshoff, C; + view all (2002) K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J VIROL , 76 (2) 802 - 816. 10.1128/JVI.76.2.802-816.2002.

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: A clinical case and review of the literature. Clinical and Laboratory Haematology , 24 (6) 385 - 387. 10.1046/j.1365-2257.2002.00460.x.

Shing, DC; Morley-Jacob, CA; Roberts, I; Nacheva, E; Coleman, N; (2002) Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture. In: Cytogenet Genome Res. (pp. 20 - 27).

Short, KA; GROVES, RW; Novelli, MR; (2002) Haemorrhage into chronic plaque psoriasis as a consequence of disseminated intravascular coagulation. Clinical and Experimental Dermatology , 27 (6) 471 - 473.

Sibtain, A; Hill, S; Goodchild, K; Shah, N; Saunders, M; Hoskin, PJ; (2002) The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen. Radiotherapy And Oncology , 62 (1) 69 - 76.

Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2002) In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in sperm. TERATOGEN CARCIN MUT , 22 (3) 227 - 234. 10.1002/tcm.10015.

Simpson, AB; Calvert, PM; Sludden, JA; Boddy, AV; Griffin, MJ; Schatzlein, A; ... Twelves, CJ; + view all (2002) Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules. ANN ONCOL , 13 (3) 399 - 402. 10.1093/annonc/mdf041.

Sinclair, AM; Bench, AJ; Bloor, AJC; Gottgens, JLB; Stanley, ML; Miller, J; ... Green, AR; + view all (2002) Rescue of the lethal scl(-/-) phenotype by the human SCL locus. BLOOD , 99 (11) 3931 - 3938.

Southworth, R; Dearling, JLJ; Medina, RA; Flynn, AA; Pedley, RB; Garlick, PB; (2002) Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique. EUR J NUCL MED MOL I , 29 (10) 1334 - 1341. 10.1007/s00259-002-0922-2.

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; ... Hartley, JA; + view all (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access
file

Spencer, DIR; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; ... Chester, KA; + view all (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. PROTEOMICS , 2 (3) 271 - 279.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? BRIT J HAEMATOL , 119 (3) 863 - 873.

Stoeber, K; Swinn, R; Prevost, AT; de Clive-Lowe, P; Halsall, I; Dilworth, SM; ... Williams, GH; + view all (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J NATL CANCER I , 94 (14) 1071 - 1079.

Sugie, K; Yamamoto, A; Murayama, K; Nonaka, I; Nishino, I; Oh, SJ; ... Hirano, M; + view all (2002) Clinicopathological features of genetically-confirmed Danon disease. Journal of the Neurological Sciences , 199 S105 - S105.

Sugie, K; Yamamoto, A; Murayama, K; Takahashi, M; Mora, M; Riggs, JE; ... Nishino, I; + view all (2002) Clinicopathological features of genetically confirmed Danon disease. Neurology , 58 (12) 1773 - 1778.

T

Tchilian, EZ; Dawes, R; Ramaley, PA; Whitworth, JA; Yuldasheva, N; Wells, RS; ... Beverley, PCL; + view all (2002) A CD45 polymorphism associated with abnormal splicing is absent in African populations. IMMUNOGENETICS , 53 (10-11) 980 - 983. 10.1007/s00251-001-0410-z.

Thomas, HD; Porter, DJ; Bartelink, I; Nobbs, JR; Cole, M; Elliott, S; ... Boddy, AV; + view all (2002) Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide. BRIT J CLIN PHARMACO , 53 (1) 83 - 91.

Thyagarajan, D; Byrne, E; (2002) Mitochondrial disorders of the nervous system: Clinical, biochemical, and molecular genetic features. Mitochondrial Function and Dysfunction , 53 93 - 144.

Tiercy, JM; Marsh, SGE; Schreuder, GMTH; Albert, E; Fischer, G; Wassmuth, R; (2002) Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. European Journal of Immunogenetics , 29 273 - 274.

Tipping, AJ; Mahon, FX; Zafirides, G; Lagarde, V; Goldman, JM; Melo, JV; (2002) Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. LEUKEMIA , 16 (12) 2349 - 2357. 10.1038/sj.leu.2402775.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; ... Lee, M; + view all (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. BIOORG MED CHEM LETT , 12 (16) 2245 - 2248.

Tsuzuki, S; Enver, T; (2002) Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein. BLOOD , 99 (9) 3404 - 3410.

V

Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2002) Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. CANCER RES , 62 (14) 4095 - 4099.

Venables, K; Winfield, E; Aird, E; Hoskin, PJ; (2002) Three-dimensional distribution of radiation within the breast: an intercomparison of departments participating in the START trial of breast radiotherapy fractionation. International Journal of Radiation Oncology Biology Physics , 55 271 - 279.

W

Wald, NJ; Hackshaw, AK; (2002) Folic acid supplementation and neural tube defects. AM J MED GENET , 109 (1) 79 - 79. 10.1002/ajmg.10292.

Wang, HW; Sharp, TV; Koumi, A; Koentges, G; Boshoff, C; (2002) Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J , 21 (11) 2602 - 2615.

Wanless, IR; Sweeney, G; Dhillon, AP; Guido, M; Piga, A; Galanello, R; ... Cohen, AR; + view all (2002) Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. BLOOD , 100 (5) 1566 - 1569. 10.1182/blood-2002-01-0306.

Ward, KN; White, RP; Mackinnon, S; Hanna, M; (2002) Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. BONE MARROW TRANSPL , 30 (12) 983 - 985. 10.1038/sj.bmt.1703774.

Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; ... Mouse Genome Sequencing Consor,; + view all (2002) Initial sequencing and comparative analysis of the mouse genome. NATURE , 420 (6915) 520 - 562. 10.1038/nature01262.

Watt, DJ; Jones, GE; Goldring, K; (2002) The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration. GLYCOCONJUGATE J , 19 (7-9) 615 - 619.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS((R)) (v2 center dot 1) and Isolex((R)) 300i (v2 center dot 5) clinical scale devices. BRIT J HAEMATOL , 118 (1) 117 - 123.

Westerman, MP; Pizzey, A; Wiener-Well, Y; Ramotar, H; Lawrie, A; Purdy, G; ... Porter, JB; + view all (2002) Circulating red cell-derived vesicles expressing phosphatidylserine are increased in thalassemia as well as in sickle cell disorders. In: BLOOD. (pp. 237A - 237A). AMER SOC HEMATOLOGY

Westin, J; Lagging, LM; Spak, F; Aires, N; Svensson, E; Lindh, M; ... Wejstal, R; + view all (2002) Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J VIRAL HEPATITIS , 9 (3) 235 - 241.

Whelan, JS; Burcombe, RJ; Janinis, J; Baldelli, AM; Cassoni, AM; (2002) A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol , 13 (1) 23 - 30.

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; ... Gotch, F; + view all (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J VIROL , 76 (6) 2634 - 2640. 10.1128/JVI.76.6.2634-2640.2002.

Y

Yaguchi, H; Ohkura, N; Tsukada, T; Yamaguchi, K; (2002) Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem , 277 (41) 38197 - 38204. 10.1074/jbc.M204132200. Gold open access

Yates, F; Malassis-Séris, M; Stockholm, D; Bouneaud, C; Larousserie, F; Noguiez-Hellin, P; ... Cavazzana-Calvo, M; + view all (2002) Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood , 100 (12) 3942 - 3949. 10.1182/blood-2002-03-0782.

Yee, TT; Beeton, K; Griffioen, A; Harrington, C; Miners, A; Lee, CA; Brown, SA; (2002) Experience of prophylaxis treatment in children with severe haemophilia. HAEMOPHILIA , 8 (2) 76 - 82.

Yong, KL; Fahey, A; Pahal, G; Linch, DC; Pizzey, A; Thomas, NSB; ... Thrasher, AJ; + view all (2002) Fetal haemopoietic cells display enhanced migration across endothelium. BRIT J HAEMATOL , 116 (2) 392 - 400.

Yong, KL; Fahey, A; Pizzey, A; Linch, DC; (2002) Influence of cell cycling and cell division on transendothelial migration of CD34(+) cells. BRIT J HAEMATOL , 119 (2) 500 - 509.

Z

Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEM BIOPH RES CO , 296 (1) 178 - 181.

Zong, JC; Ciufo, DM; Viscidi, R; Alagiozoglou, L; Tyring, S; Rady, P; ... Hayward, GS; + view all (2002) Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J CLIN VIROL , 23 (3) 119 - 148.

This list was generated on Mon Dec 22 04:57:27 2014 GMT.